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Liver receptor homolog 1 transcriptionally regulates
human bile salt export pump expression
Xiulong Song, Rajani Kaimal, Bingfang Yan, and Ruitang Deng1
Department of Biomedical and Pharmaceutical Sciences, Center for Pharmacogenomics and Molecular
Therapy, College of Pharmacy, University of Rhode Island, Kingston, RI
Abstract The metabolic conversion of cholesterol into bile
acids in liver is initiated by the rate-limiting cholesterol 7a-
hydroxylase (CYP7A1), whereas the bile salt export pump
(BSEP) is responsible for the canalicular secretion of bile
acids. Liver receptor homolog 1 (LRH-1) is a key transcrip-
tional factor required for the hepatic expression of
CYP7A1. We hypothesized that LRH-1 was also involved in
the transcriptional regulation of BSEP. In support of our
hypothesis, we found that overexpression of LRH-1
induced, whereas knockdown of LRH-1 decreased, BSEP
expression. Consistent with its role in transcriptional reg-
ulation, LRH-1 dose-dependently transactivated the BSEP
promoter. In addition, such transactivation by LRH-1
was required for maximal induction of BSEP expression
through the bile acid/farnesoid X receptor (FXR) activa-
tion pathway. Bioinformatic and mutational analysis led to
the identification of a functional liver receptor homolog
1-responsive element (LRHRE) in the BSEP promoter. Spe-
cific binding of LRH-1 to the LRHRE and recruitment of
LRH-1 to the BSEP promoter were demonstrated by elec-
trophoretic mobility shift assay and chromatin immuno-
precipitation assay, respectively. In conclusion, LRH-1
transcriptionally activated the BSEP promoter and func-
tioned as a modulator in bile acid/FXR-mediated BSEP
regulation. These results suggest that LRH-1 plays a sup-
porting role to FXR in maintaining hepatic bile acid lev-
els by coordinately regulating CYP7A1 and BSEP for bile
acid synthesis and elimination, respectively.—Song, X., R.
Kaimal, B. Yan, and R. Deng. Liver receptor homolog 1
transcriptionally regulates human bile salt export pump
expression. J. Lipid Res. 2008. 49: 973–984.
Supplementary key words bile acids & bile acid synthesis and
elimination & cholesterol & cholesterol metabolism & farnesoid X
receptor & small heterodimer partner & nuclear receptors
Cholesterol metabolizing into bile acids and subse-
quent elimination through bile secretion is a major path-
way for removing excessive cholesterol from the body.
The metabolic conversion of cholesterol to bile acids in
the liver is initiated by the rate-limiting enzyme choles-
terol 7a-hydroxylase (CYP7A1) (1, 2), whereas the bile
salt export pump (BSEP) is responsible for the canalicu-
lar secretion of bile acids (3–6). Therefore, CYP7A1 and
BSEP are two key players in maintaining cholesterol and
bile acid homeostasis. After being synthesized in the
liver by a cascade of enzymes including CYP7A1, bile acids
are secreted into the bile through BSEP, reabsorbed in
the small intestines via apical sodium-dependent bile
acid transporter (ASBT) (7, 8) and basolateral organic
solute transporters a and b (Osta and Ostb) (9), returned
to the liver, and resecreted into bile, completing the en-
terohepatic circulation of bile acids. The canalicular se-
cretion of bile acids through BSEP is the rate-limiting
step in the enterohepatic circulation (5, 6). Through
each circulation, ?5% of bile acids are eliminated via
fecal excretion.
The expression of CYP7A1 and BSEP is coordinately
regulated by multiple transactivation pathways, notably
the bile acid/farnesoid X receptor (FXR) signaling path-
way (10–16). Bile acids, as FXR agonists, strongly repress
CYP7A1 expression through a negative feedback circuit
(10–14), whereas bile acids markedly induce BSEP ex-
pression by activating FXR (15, 16). Such coordinated
feedback and feed-forward regulation of CYP7A1 and
BSEP by bile acids represents an excellent mechanism for
preventing the excessive accumulation of toxic bile acids
in hepatocytes. On the other hand, enhancing bile acid
elimination through increasing BSEP expression favors
cholesterol conversion into bile acids and is a possible
mechanism for the hypolipidemic agent guggulsterone
to exert its cholesterol-lowering effect (17, 18).
The orphan nuclear receptor liver receptor homolog 1
(LRH-1) is a transcriptional factor expressed in multiple
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organs and tissues, including liver and intestine. Studies
have demonstrated that LRH-1 regulates a set of target
genes encoding proteins important for the biosynthesis
and transport of cholesterol and bile acids, including
CYP7A1 (19, 20), ASBT (21, 22), and Osta and Ostb (23).
In the liver, LRH-1 is required for the maximal hepatic
expression of CYP7A1 (19, 20). In the small intestine, LRH-
1 regulates ASBT (21, 22) and Osta and Ostb (23). In
addition, LRH-1 transactivates scavenger receptor class B
type I (24), which mediates the uptake of circulating cho-
lesterol into liver hepatocytes; ABCG5/G8, which is re-
sponsible for the canalicular secretion of cholesterol (25);
cholesteryl ester transfer protein, which transfers choles-
teryl esters from high density lipoproteins to triglyceride-
rich lipoproteins (26); and apolipoprotein A-I, which
functions as an acceptor for phospholipid and cholesterol
(27). Therefore, LRH-1 is a master transcriptional regula-
tor in maintaining cholesterol and bile acid homeostasis.
In this study, we demonstrate that LRH-1 transcription-
ally regulates BSEP expression through a functional liver
receptor homolog 1-responsive element (LRHRE) in the
BSEP promoter and functions as a modulator in bile acid/
FXR-mediated BSEP regulation. Thus, LRH-1 plays a sup-
porting role to FXR in maintaining hepatic bile acid lev-
els by coordinately regulating CYP7A1 and BSEP for bile
acid synthesis and elimination, respectively.
MATERIALS AND METHODS
Chemicals and supplies
Chenodeoxycholic acid (CDCA) and DMSO were purchased
from Sigma (St. Louis, MO). DMEM, LipofectAMINE, and Plus
Reagent were from Invitrogen (Carlsbad, CA). Kits for lucifer-
ase detection and the null-Renilla luciferase plasmid were from
Promega (Madison, WI). Fetal bovine serum and 1003 non-
essential amino acids were from HyClone (Logan, UT). Unless
specified otherwise, all other reagents were purchased from
Fisher Scientific (Suwanee, GA). Oligonucleotides for PCR
amplification, site-directed mutagenesis, cloning, and gel-shift
assays were chemically synthesized by Invitrogen. Polyclonal
antibodies against human LRH-1 (sc-25389X) and Jun-B (sc-
73X) were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA).
Plasmid constructs
The preparation of the human BSEP promoter reporter
pBSEP(22.6kb) was described elsewhere (28). The mouse pro-
moter reporter pmBSEP(22.6kb) was constructed by cloning a
2.6-kb fragment upstream of the transcription start site of
mouse BSEP into the pGL4.10 vector (Promega) at the NheI
and XhoI sites. The rat BSEP promoter reporter prBSEP(22kb)
was constructed by cloning a 2-kb fragment upstream of the
transcription start site of rat BSEP into the pGL4.10 vector at the
KpnI and SacI sites. All of the reporter constructs were sequence-
verified before use in the experiments. The sequences of the
PCR primers are listed in Table 1. Mouse LRH-1 and small
heterodimer partner (SHP) expression constructs, pcDNA3-
LRH-1 and pCD8-mSHP, were kindly provided by Dr. Wang Li
(University of Kansas Medical Center, Kansas). Expression plas-
mid for the human nuclear receptor FXR were kindly provided
by Dr. David Mangelsdorf (University of Texas Southwestern
Medical Center, Dallas).
Site-directed mutagenesis
Mutagenesis was performed using the QuickChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA). Three or
four nucleotide substitutions in the LRHRE core sequence were
TABLE 1. Sequences of oligonucleotides used in these studies
Oligonucleotides Sequences (5¶–3¶)
pmBSEP(22.6kb)-sense TGCCATTTCTTGAGGTTGGCTAGCTCTTAACC
pmBSEP(22.6kb)-antisense GAGAGACGCCACTGTGGAAATCAGGGTTGTACACC
prBSEP(22kb)-sense TAGTTAGGGTTTCCTTTCCTGCACAACCATCATGACC
prBSEP(22kb)-antisense GAGAGACCCCACTGTGGAAAGTCAGGATTGTACACC
LRHRE1 Mut-sensea GAATCAGCAATTTCCTCGAGCTGTTGACACCCTC
LRHRE1 Mut-antisense GAGGGTGTCAACAGCTCGAGGAAATTGCTGATTC
LRHRE2 Mut-sense CAATTTGCCTCTCGTTCCTCGAGGAATCAGCAATTTCC
LRHRE2 Mut-antisense GGAAATTGCTGATTCCTCGAGGAACGAGAGGCAAATTG
LRHRE3 Mut-sense GCTTTTCTTTGCTGCTCGAGATATATTTGAGATTTG
LRHRE3 Mut-antisense CAAATCTCAAATATATCTCGAGCAGCAAAGAAAAGC
LRHRE4 Mut-sense GAAGGAAAGTCTTAGGACTCGAGGACCTGTGAGCAGAT
LRHRE4 Mut-antisense ATCTGCTCACAGGTCCTCGAGTCCTAAGACTTTCCTTC
LRH-1 siRNA-sense AAGGATCCATCTTCCTGGTTA
LRHRE1 probeb AATCAGCAATTTCCAAGGCCTGTTGACA
LRHRE1 Mut AATCAGCAATTTCTCGAGCCTGTTGACA
CYP7A1 LRHRE ACTTAGTTCAAGGCCAGTTACTA
pBSEP(+35b) TTCACAACCTTTTCCAACCTCGG
pBSEP(2260b) GGGTTGGGATAGCCTGAATTCCAGGGCTC
pBSEP(2805b) TTTGGGCCTCTCAACAGCCCTAGGAGTTGG
pBSEP(2995b) CACTGGCCCATCAATTGCATTTCAGAGC
pBSEP(21132b) AACCCAAAATTATAACATATAATTTTATATG
pBSEP(21305b) GGGTCCTAATTGGTGCCAAATCCAATATTAC
pBSEP(21410b) ACCTTTGCTGTGCTGAAGTTATTGACAGCA
pBSEP(21629b) TCTATAAGATGAAGTTGTTGGATGATATATC
aMutated nucleotides are shown in boldface.
bThe core sequences of the liver receptor homolog 1-responsive element are underlined.
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introduced into pBSEP(22.6kb), resulting in LRHRE1 Mut,
LRHRE2 Mut, LRHRE3 Mut, and LRHRE4 Mut. The sequences
of the mutagenic oligonucleotides are listed in Table 1. The
mutagenesis reactions were performed essentially according to
the manufacturer’s manual. The resulting mutants were sub-
jected to sequence analysis to confirm that the desired substitu-
tions were made without introducing errors.
Reporter luciferase assay
Huh 7 cells were plated on 24-well plates in DMEM
supplemented with 10% fetal bovine serum at a density of 8 3
104 cells per well and cultured overnight. Transient transfection
was conducted with LipofectAMINE and Plus Reagent (Invitro-
gen) as described previously (28). For most of the transfections,
standard amounts of plasmid DNA used per well were 100 ng of
promoter reporter or empty pGL4.10 vector, 50–100 ng of nu-
clear receptor expression plasmid (FXR, LRH-1, and SHP), and
10 ng of the null-Renilla luciferase plasmid as an internal control.
The luciferase activities were assayed at 36 h after transfection
with the Dual-Luciferase Reporter Assay System as described
previously (28). Briefly, transfected cells were washed once with
PBS and lysed by adding 100 ml of passive lysis buffer (Promega)
with gentle rocking for 30 min. Cell lysates (10 ml) were trans-
ferred to a 96-well reader plate, and luciferase activities were
measured with an EG&G Berthold Microplate Luminometer
(Perkin-Elmer, Boston, MA). The firefly luminescence was nor-
malized based on the Renilla luminescence signal, and the ratio
of treatment over control values served as fold activation. Data
are presented as means 6 SD of at least three separate ex-
periments. For experiments with FXR agonist treatments, 16 h
after transfection, cells were treated with 10 mM bile acid CDCA
or 0.1% DMSO as a negative control for 30 h, followed by the
detection of luciferase activity.
RNA interference
Small interfering RNAs (siRNAs) against human LRH-1 and
enhanced green fluorescent protein (eGFP) were chemically
synthesized by Qiagen (Valencia, CA). The sequences for LRH-1
siRNA and eGFP siRNA are given in Table 1. The selected LRH-1
siRNA exhibited potent specific silencing on LRH-1 expression
(27). For the experiments to determine the effect of LRH-1
knockdown on endogenous BSEP expression, Huh 7 cells seeded
on 12-well plates at 70% confluence were transfected with 5 or
10 nM LRH-1 siRNA using HiPerFect Transfection Reagent
(Qiagen) according to the instructions of the manufacturer.
Cells were also transfected with siRNA vehicle buffer or 10 nM
eGFP siRNA as a negative control. Forty-eight hours after trans-
fection, transfected cells were lysed for RNA isolation. Quantifi-
cation of BSEP and LRH-1 mRNA was carried out by the TaqMan
real-time PCR assay as described below. For experiments to de-
termine the effect of LRH-1 silencing on BSEP promoter activity,
Huh 7 cells seeded on 24-well plates were cotransfected with
pBSEP(22.6 kb) reporter (100 ng), 5 or 10 nM LRH-1 siRNA,
and 10 ng of the null-Renilla luciferase plasmid with TransMes-
senger Transfection Reagent (Qiagen) as instructed. Promoter
activity was assayed with the dual luciferase detection system at
48 h after transfection.
Quantitative real-time PCR
Total RNA isolation from transfected or chemically treated
cells and subsequent real-time PCR assays were performed es-
sentially as described (17). Briefly, cDNA was synthesized with
2 mg of total RNA and random primers in a total volume of
25 ml and subjected to real-time PCR using the TaqMan Gene
Expression Assay (Applied Biosystems, Foster City, CA). The
TaqMan assay probes for BSEP (assay identifier: Hs00184824_m1),
LRH-1 (assay identifier: Hs00187067_m1), FXR (assay identifier:
Hs00231968_m1), SHP (assay identifier: Hs00222677_m1),
and GAPDH (assay identifier: 4352934E) were purchased from
Applied Biosystems. Real-time PCR was performed using the
TaqMan Universal PCR Master Mix (Applied Biosystems) in a
total volume of 20 ml containing 10 ml of Universal PCR Mas-
ter Mix, 1 ml of gene-specific TaqMan probe mixture, and 5 ml
of cDNA templates. The cycling profile was as follows: 50jC
for 2 min, 95jC for 10 min, followed by 40 cycles of 15 s at 95jC
and 1 min at 60jC, as recommended by the manufacturer.
Amplification and quantification were done with the Applied
Biosystems 7500 Real-Time PCR System.
Nuclear extract preparation and electrophoretic mobility
shift assays
Nuclear extracts of Huh 7 cells transfected with LRH-1 were
prepared using the NE-PER Nuclear and Cytoplasmic Extrac-
tion kit (Pierce, Rockford, IL) according to the instructions of
the manufacturer. All of the preparation procedures were carried
out at 4jC. The total protein concentrations were determined
by the BCA protein assay (Pierce). The prepared nuclear extracts
were stored at 280jC until use. The electrophoretic mobility
shift assays (EMSAs) were performed using the LightShift
Chemiluminescent EMSA kit (Pierce). The sense and antisense
oligonucleotide probes containing the functional LRHRE
(LRHRE1) were biotin-labeled at the 5¶ end (Invitrogen) and
annealed by heating at 94jC for 5 min followed by gradually
cooling to room temperature. Nuclear proteins (10 mg) were
incubated with biotin-labeled probe (20 fM) in a final volume
of 20 ml in 13 DNA binding buffer containing 2.5% glycerol,
50 ng/ml poly(dI.dC), and 0.05% Nonidet P-40. To establish
the specificity of the binding, competition assays were included
using various competing oligonucleotides, including unlabeled
LRHRE1 (103 and 503), mutated LRHRE1 (503), and the
LRHRE from human CYP7A1 (503). The sequences of those
oligonucleotides are listed in Table 1. For the competition ex-
periments, nuclear extracts were first incubated with excess
competing oligonucleotides (10–503) and then mixed with the
biotin-labeled probe. To determine whether LRH-1 is a com-
ponent of the protein complex binding to the probe, supershift
assays were performed using polyclonal antibodies against hu-
man LRH-1 (sc-25389; Santa Cruz Biotechnology). Antibodies
against Jun-B were included as a negative control. For the su-
pershift assays, antibodies (2 mg) were incubated with nuclear
extracts at 4jC for 30 min before adding the biotin-labeled
probe. The protein-DNA complexes were resolved by 6% PAGE,
transferred to nylon membranes, and detected by chemilumi-
nescence according to the protocol provided by the manufac-
turer (Pierce).
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assay was performed
with the ChIP-IT Express Kit (Active Motif, Carlsbad, CA). Chro-
matins were prepared from the following sources: Huh 7 cells
transfected with LRH-1 with or without CDCA treatment and nor-
mal human liver tissue. For the preparation of chromatin from
Huh 7 cells, cells seeded on six-well plates were transfected with
2 mg of LRH-1 plasmid, followed by treatment of transfected cells
with 10 mM CDCA or vehicle DMSO (0.1%) for 24 h. Cells were
fixed with 1% formaldehyde-containing DMEM at room temper-
ature for 10 min and then treated with Glycine Stop-Fix solution.
The cells werewashedwith PBS, harvested, and centrifuged at 720 g
for 10 min at 4jC. Pellets were resuspended in 1 ml of lysis buffer
and incubated on ice for 30 min, then processed with a Dounce
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homogenizer for 10 strokes and centrifuged at 2,400 g for 10 min
at 4jC. Nuclei were suspended in 0.5 ml of Shearing Buffer and
sonicated with the Branson Sonifier 150 (Branson, Danbury, CT)
by three strokes of 20 s pulse at power level 5 with a 30 s interval on
ice to achieve optimal chromatin sizes ranging from 400 to 800 bp.
The sheared chromatins were collected as the supernatant after
centrifuging at 12,000 g for 12 min. The preparation of chroma-
tins from human liver tissues was carried out as described (29).
Briefly, normal human liver tissues from two individual donors
were obtained from the Liver Tissues Procurement and Distribu-
tion System (University of Minnesota). Upon arrival, the liver
tissues were frozen in liquid nitrogen and pulverized into powder,
followed by cross-linking with 1% formaldehyde for 15 min at
room temperature and subsequent termination of cross-linking
with the addition of Glycine Stop-Fix solution. The soluble chro-
matins were prepared by following the same procedure described
above. For ChIP experiments, 50ml aliquots of sheared chromatins
were used for immunoprecipitation with the addition of 25 ml of
protein Gmagnetic bead suspension and 2mg of LRH-1 antibodies
(sc-25389; Santa Cruz Biotechnology) or 2 mg of IgG antibodies as
a negative control (Active Motif). The chromatins were eluted
from the magnetic beads after washing with ChIP buffers, fol-
lowed by reversing the cross-link with the addition of Reverse
Cross-link Buffer and heating at 94jC for 15 min. The proteins in
the solution were digested by proteinase K at 37jC for 1 h, fol-
lowed by the addition of proteinase K stop solution to terminate
the reaction. The final volume of the eluted chromatin DNA
was 100 ml. For the preparation of input DNA, 10 ml of sheared
chromatins was diluted up to 100 ml to reverse cross-link and
proteinase K digestion, followed by 10-fold dilution with water.
Four sets of primers were used for PCR amplification. The
sequences of those primers are listed in Table 1. The primer
set flanking the LRHRE1 site at position 2175 bp consisted of
the forward primer pBSEP(2260b) and the reverse primer
pBSEP(135b). The expected PCR product is a 295 bp frag-
ment encompassing sequence from nucleotides 135 to 2260 in
the BSEP promoter. The negative control primer set consisted
of the forward primer pBSEP(2995b) and the reverse primer
pBSEP(2805b) and amplified a 190 bp fragment encompassing
the sequence from nucleotides 2995 to 2805 in the BSEP pro-
moter, a region 630 bp upstream the LRHRE1 site. The two
primer sets detecting the recruitment of LRH-1 to LRHRE3
and LRHRE4 were pBSEP(21305b)/pBSEP(21132b) and
pBSEP(21629b)/pBSEP(21410b), respectively. PCR amplifi-
cation was carried out in a final volume of 25 ml with 2 ml of
eluted chromatin DNA, input DNA, or water (mock) as tem-
plate and 1 unit of high-fidelity Taq DNA polymerase (Invitro-
gen) with the following cycling parameters: 94jC for 3 min,
40 cycles of 94jC for 45 s, 53jC for 45 s, and 68jC for 45 s,
followed by an extension at 68jC for 5 min. PCR products
were resolved on 2% agarose gels and scanned with the Ty-
phoon 9410 Image Scanner (GE Healthcare, Piscataway, NJ).
Statistical analysis
Student’s t-test was applied to pair-wise comparisons to de-
termine statistical significance. Values of 0.05 or lower were con-
sidered significant.
RESULTS
Overexpression of LRH-1 induced BSEP expression
To determine whether LRH-1 is involved in the
regulation of BSEP expression, human hepatoma Huh 7
cells were transfected with LRH-1 expression plasmid,
followed by detection of BSEP mRNA by real-time PCR. As
shown in Fig. 1A, cells transfected with 100 or 200 ng of
LRH-1 plasmid exhibited an increase in BSEPmRNA level,
?2.5- to 3-fold induction compared with the cells trans-
fected with empty expression vector. Such increased levels
were comparable to those in cells transfected with 200 ng
of FXR plasmid DNA. To eliminate the possibility that
LRH-1 may modulate FXR expression and in turn upregu-
late BSEP expression, FXR mRNA levels were measured
by real-time PCR after LRH-1 transfection. As shown in
Fig. 1B, LRH-1 had a minimal effect on FXR expression,
suggesting that LRH-1-mediated induction of BSEP
expression was independent of FXR. On the other hand,
overexpression of FXR also had no effect on endoge-
nous LRH-1 expression (Fig. 1B), suggesting that LRH-1 is
not an FXR target gene. Together, these results demon-
strate that LRH-1 induced BSEP expression in an FXR-
independent manner.
LRH-1 was required for maximal BSEP expression
To confirm the finding, we next performed experi-
ments to determine the effect of LRH-1 knockdown by
siRNA on BSEP expression. We have shown previously
that BSEP is expressed at a relatively high level in hu-
man hepatoma Huh 7 cells (28). Therefore, the effect of
LRH-1-specific siRNA on BSEP expression was evaluated
in Huh 7 cells. A validated potent and specific hu-
man LRH-1 siRNA was used to silence LRH-1 expression
(27), and its effect on BSEP expression was assessed by
quantitative real-time PCR. As expected, transfection of
Huh 7 cells with 5 or 10 nM LRH-1 siRNA for 48 h resulted
in a reduction of LRH-1 expression (Fig. 1C). More im-
portantly, and in parallel with LRH-1 reduction, BSEP
mRNA levels were also decreased significantly in cells
transfected with LRH-1 siRNA (Fig. 1C). Reductions of
.50% in BSEP mRNA levels were detected in cells trans-
fected with 10 nM LRH-1 siRNA. As a control, transfection
of eGFP-specific siRNA hadminimal effects on both LRH-1
and BSEP mRNA levels (Fig. 1C), indicating the specificity
of the effect. These data indicated that LRH-1 was required
for maximal expression of BSEP, consistent with the pre-
vious results from LRH-1 overexpression experiments.
LRH-1 transactivated the BSEP promoter
To determine whether the upregulation of BSEP
expression by LRH-1 is mediated at the transcriptional
level rather than through other posttranscriptional mech-
anisms, such as stabilizing BSEP mRNA, the effect of
LRH-1 on human BSEP promoter activation was evaluated.
Huh 7 cells were cotransfected with the BSEP promoter
reporter pBSEP(22.6kb) (28) and increasing amounts of
LRH-1 expression plasmid or empty vector (0, 5, 25, 100,
and 200 ng). As shown in Fig. 2A, LRH-1 dose-dependently
activated the BSEP promoter, whereas such activation
was not detected in cells cotransfected with increasing
amounts of control vector. Increased activation was de-
tected in cells transfected with 25 ng of LRH-1, with a
976 Journal of Lipid Research Volume 49, 2008
 at Univ of Rhode Island, on O
ctober 23, 2018
w
w
w
.jlr.org
D
ow
nloaded from
 
further increase in cells transfected with 100 and 200 ng of
LRH-1 (4- to 5-fold increase) (Fig. 2A). These data indi-
cated that LRH-1 regulated BSEP expression at the transcrip-
tional level, consistent with its function as a transcriptional
factor in regulating other LRH-1 target genes (19–26).
To further confirm such findings, we next tested
whether knockdown of LRH-1 by siRNA has an effect on
the basal activity of the BSEP promoter. It should be
mentioned that endogenous LRH-1 expression in Huh
7 cells was confirmed by RT-PCR (Fig. 1B). Huh 7 cells
were transfected with pBSEP(22.6kb) and LRH-1-specific
Fig. 2. LRH-1 transactivated the human BSEP promoter. A: Huh
7 cells seeded on 24-well plates were transfected with 100 ng of
the human BSEP promoter reporter pBSEP(22.6kb) (28), 10 ng
of the null-Renilla luciferase plasmid as an internal control, and
increasing amounts of LRH-1 plasmid DNA or empty vector as a
negative control (0, 5, 25, 100, and 200 ng). The luciferase activities
were assayed at 36 h after transfection with the Dual-Luciferase
Reporter Assay System. The firefly luminescence was normalized
based on the Renilla luminescence signal. B: Huh 7 cells were
transfected with pBSEP(22.6kb) (100 ng) and 5 or 10 nM LRH-
1-specific siRNA. Treatments with vehicle buffer or eGFP-specific
siRNA (10 nM) were also included in the experiment as negative
controls. Forty-eight hours after transfection, promoter activities
were detected using the Dual-Luciferase Reporter Assay System.
The asterisks indicate significant differences between vehicle and
siRNA treatment groups by Student’s t-test (P , 0.05). All data are
presented as means 6 SD of at least three separate experiments.
Fig. 1. Liver receptor homolog 1 (LRH-1) upregulated bile salt
export pump (BSEP) expression. A: Huh 7 cells seeded on 12-well
plates were transfected with LRH-1 expression plasmid, empty
vector as a negative control, or farnesoid X receptor (FXR) ex-
pression plasmid as a positive control. Forty-eight hours after
transfection, total RNA was isolated and subjected to cDNA syn-
thesis and real-time PCR using the TaqMan Gene Expression As-
say with a BSEP-specific probe. The mRNA levels for GAPDH
were detected as an internal control. The PCR cycle times (Ct)
value in cells transfected with vector control is given at the top of
the column. B: After the same treatment of Huh 7 cells as in A,
the mRNA levels of LRH-1 and FXR were measured by real-time
PCR using LRH-1- and FXR-specific probes. The Ct values for
FXR and LRH-1 in cells transfected with vector control are given
at the top of the columns. C: Huh 7 cells seeded on 12-well plates
were transfected with 5 or 10 nM LRH-1 small interfering RNA
(siRNA). Cells were also transfected with vehicle buffer or 10 nM
enhanced green fluorescent protein (eGFP) siRNA as a negative
control. Forty-eight hours after transfection, cells were lysed for
RNA isolation and quantification by real-time PCR. LRH-1- and
BSEP-specific probes were used to detect LRH-1 and BSEP mRNA
expression levels, respectively. Student’s t-test was applied to de-
termine the significance of the differences between siRNA- and
vehicle-treated groups. The asterisks indicate significant differ-
ences (P , 0.05). All data are presented as means 6 SD of at
least three separate experiments.
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siRNA, followed by detection of reporter activity. The
BSEP promoter had relatively low basal activity. However,
such low basal activity was further decreased by ?35–40%
by LRH-1 siRNA (Fig. 2B). As expected, siRNA against
eGFP had no effect on BSEP promoter basal activity
(Fig. 2B). These results demonstrated that knockdown
of LRH-1 by siRNA resulted in a decrease in BSEP pro-
moter activation, consistent with the finding that LRH-1
knockdown led to a decrease in BSEP mRNA expression
(Fig. 1C).
LRH-1 had a modulating effect on the bile acid/
FXR-mediated regulation of BSEP expression
It is well established that BSEP expression is regulated
by bile acids through activating FXR (15, 16). To deter-
mine whether LRH-1 has modulating effect on bile acid/
FXR-mediated regulation of BSEP expression, Huh 7 cells
were transfected with LRH-1, followed by treatment of
transfected cells with FXR agonist CDCA or vehicle DMSO.
As shown in Fig. 3A, compared with cells transfected with
vector, cells transfected with LRH-1 exhibited increased
basal (DMSO) as well as CDCA-induced BSEP expression.
Similar effects were observed in cells transfected with FXR
(Fig. 3A). These results indicated that LRH-1 modulated
the bile acid/FXR-mediated induction of BSEP expression
by increasing its basal expression. To confirm this finding,
the effect of LRH-1 silencing by siRNA on the bile acid/
FXR-mediated regulation of BSEP expression was deter-
mined. As shown in Fig. 3B, knockdown of LRH-1 with
10 nM siRNA resulted in a significant decrease in the
CDCA-mediated induction of BSEP expression. Such a
decrease was not observed with eGFP-specific siRNA, indi-
cating the specificity of the action. It should be mentioned
that silencing with 5 nM siRNA also resulted in decreased
BSEP expression, although it was not statistically signifi-
cant. Thus, we demonstrated that the bile acid/FXR-
mediated regulation of BSEP expression was modulated by
the levels of LRH-1.
To further confirm these results, the effect of LRH-1 on
the bile acid/FXR-mediated transactivation of the BSEP
promoter was investigated. Huh 7 cells were cotransfected
with the BSEP promoter reporter and FXR in the absence
or presence of increasing amounts of LRH-1. The cells
were then treated with CDCA or DMSO, followed by the
detection of BSEP promoter activity. As shown in Fig. 3C,
LRH-1 dose-dependently increased basal (DMSO) as well
as CDCA-mediated activation of the BSEP promoter, con-
sistent with the effects of LRH-1 overexpression on BSEP
mRNA expression. Thus, we conclude that LRH-1 func-
tioned as a modulator in the bile acid/FXR-mediated reg-
ulation of BSEP expression.
Identification of functional LRHREs in the
BSEP promoter
LRH-1 transactivates its target gene by binding to the
LRHRE in the target gene promoters with the consensus
sequence YCAAGGYCR (19–26). Bioinformatic analysis
led to identification of four potential LRHREs in the
Fig. 3. LRH-1 modulated the bile acid/FXR-mediated regulation of
BSEP expression. A: Huh 7 cells seeded on 12-well plates were trans-
fected with LRH-1, FXR, or vector as a control, followed by treatment
of transfected cells with chenodeoxycholic acid (CDCA; 10 mM) or ve-
hicle DMSO (0.1%) for 30 h. Total RNA was isolated and subjected
to cDNA synthesis and real-time PCR using the TaqMan Gene Expres-
sion Assay with a BSEP-specific probe. The mRNA levels for GAPDH
were detected as an internal standard. B: Huh 7 cells were transfected
withLRH-1 siRNA, vehiclebuffer,oreGFPsiRNA.Thirty-sixhours after
transfection, the cells were treated with CDCA (10 mM) or vehicle
DMSO (0.1%) for 24 h. Cells were lysed for RNA isolation and BSEP
mRNA quantification by real-time PCR. The asterisks indicate sig-
nificant differences (P, 0.05) between vehicle and treatment groups.
C: Huh 7 cells seeded on 24-well plates were cotransfected with the
BSEP promoter reporter pBSEP(22.6kb) (100 ng), FXR expression
plasmid (5 ng), and the null-Renilla luciferase plasmid (10 ng) in the
absence or presence of increasing amounts of LRH-1. Sixteen hours
after transfection, cells were treated with CDCA (10 mM) or vehi-
cle DMSO (0.1%) for 30 h, followed by detection of promoter ac-
tivity with the Dual-Luciferase Reporter Assay System. All data are
presented as means6 SD of at least three separate experiments.
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BSEP promoter at nucleotides 2175, 2195, 21,195, and
21,510 bp (Fig. 4A). To determine whether any of those
LRHREs are responsible for LRH-1-mediated activation of
the BSEP promoter, each of the four sites was mutated by
site-directed mutagenesis, resulting in mutants LRHRE1,
-2, -3, and -4 Mut. The abilities of those mutants to re-
spond to LRH-1 were evaluated in comparison with the
wild type. As shown in Fig. 4B, mutation of the LRHRE3
and LRHRE4 sites had no significant effect on LRH-1-
mediated transactivation of BSEP promoter, indicating
that those two sites were not functionally involved in the
transactivation. However, disruption of LRHRE1 resulted
in a significant decrease in transactivation compared with
the wild type (1.5- vs. 4.5-fold), suggesting that LRHRE1 is
functionally involved in LRH-1-mediated transactivation
of BSEP promoter. Surprisingly, disruption of LRHRE2
strongly enhanced the activation (?13-fold induction), in-
dicating a potential negative regulatory mechanism through
LRHRE2. Together, these data showed that LRHRE1 was
responsible for LRH-1 to mediate transactivation.
We had demonstrated previously that LRH-1 had a
modulating effect on bile acid/FXR-mediated regulation
of BSEP expression. We hypothesized that mutation of the
functional LRHRE1 would have a repressive effect on bile
acid/FXR-mediated activation of BSEP promoter. Indeed,
as shown in Fig. 4C, cells cotransfected with LRHRE1 Mut,
LRH-1, and FXR exhibited a significant decrease in both
basal (DMSO) and CDCA-mediated activation, indicat-
ing that LRHRE1 is required for maximal activation of
BSEP promoter by bile acid/FXR. Mutation in LRHRE2
markedly increased, whereas mutation in LRHRE3 and
LRHRE4 had minimal effects on both basal (DMSO) and
CDCA-mediated activation (Fig. 4C), consistent with the
results from the previous experiment. Thus, we identified
LRHRE1 as the functional cis element supporting LRH-1-
mediated transactivation of BSEP.
LRH-1 specifically bound to LRHRE1
To determine whether LRH-1 specifically binds to
LRHRE1, a series of EMSAs were performed with a biotin-
labeled LRHRE1 oligonucleotide as a probe and nuclear
extracts prepared from LRH-1-transfected Huh 7 cells. As
shown in Fig. 5, lane 2, three major bands were shifted
after mixing the probe with nuclear extracts, indicating
that multiple DNA/protein complexes were formed. To
determine which band represents the specific binding of
LRH-1 to the LRHRE1 oligonucleotide, a series of com-
petition assays were carried out. As shown in lanes 3 and
4, themiddle and bottom bands were readily competed out
by 103 or 503 unlabeled LRHRE1 oligonucleotide,
indicating that those two bands represent two specific
complexes formed by nuclear proteins with the LRHRE1
oligonucleotide. Competition with an oligonucleotide-
containing CYP7A1 LRHRE resulted in disappearance of
the bottom band (Fig. 4A, lane 5), whereas such band was
not competed out by amutant LRHRE1 oligonucleotide in
which the core sequence of LRHRE1 was mutated (Fig. 5,
lane 6), suggesting that the bottom band represents the
specific complex formed by LRH-1 and the LRHRE1 oli-
Fig. 4. Mutational analyses of liver receptor homolog 1-responsive
elements (LRHREs) in the BSEP promoter. A: The locations
and sequences of the wild type and corresponding mutants of the
four potential LRHREs in the BSEP promoter are presented. B:
Mutagenesis was performed using the QuickChange site-directed
mutagenesis kit. Three or four nucleotide substitutions in the
LRHRE core sequence were introduced into pBSEP(22.6kb),
resulting in mutants LRHRE1 Mut, LRHRE2 Mut, LRHRE3 Mut,
and LRHRE4 Mut. Huh 7 cells were cotransfected with the wild
type, mutant reporters, or pGL4.10 vector (100 ng), with LRH-1
plasmid DNA (100 ng) or empty expression vector (100 ng) as a
control. Luciferase activities were assayed at 48 h after transfection.
Student’s t-test was applied to analyze the differences between the
wild type andmutants. The asterisks indicate significant differences
(P , 0.05). C: Huh 7 cells were cotransfected with the wild type,
mutants, or pGL4.10 vector (100 ng), the LRH-1 construct (100
ng), the FXR expression plasmid (50 ng), and the null-Renilla
luciferase plasmid (10 ng). Sixteen hours after transfection, cells
were treated with CDCA (10 mM) or vehicle DMSO (0.1%) for
30 h. Promoter activity was detected by the Dual-Luciferase
Reporter Assay System. The asterisks indicate significant differ-
ences (P , 0.05). All data are presented as means 6 SD of at
least three separate experiments.
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gonucleotide. To further confirm this finding, supershift
assays with antibodies against LRH-1 or Jun-B as a negative
control were performed. As shown in Fig. 5, lane 7, pre-
incubation of LRH-1 antibodies with nuclear extracts
resulted in disappearance of the bottom band, suggesting
that the binding of LRH-1 antibodies to LRH-1 interferes
with its binding to the LRHRE1 oligonucleotide, prevent-
ing the formation of the DNA/LRH-1 complexes. As ex-
pected, no effect was detected with preincubation with
Jun-B antibodies (Fig. 5, lane 8), indicating the specificity
of the effect. Thus, the data confirmed that the bottom
band resulted from the specific binding of LRH-1 to the
LRHRE1 oligonucleotide.
It should be mentioned that the top band shifted in
Fig. 5, lanes 2–8, represented a nonspecific complex,
whereas the middle band represented a specific complex
formed by other nuclear proteins (other than LRH-1) with
the sequences flanking the LRHRE1 site in the LRHRE1
oligonucleotide, which contained 12 and 7 additional
nucleotides on the 5¶ and 3¶ sides of the LRHRE1 site,
respectively. Two lines of evidence support this conclu-
sion. First, this band was competed out by unlabeled
wild-type as well as mutant LRHRE1 oligonucleotides
(Fig. 5, lanes 3, 4, 6) but not by the CYP7A1 LRHRE
(Fig. 5, lane 5). Second, preincubation of nuclear extracts
with antibodies against LRH-1 had no effect on the for-
mation of this complex. Thus, the data indicate that other
nuclear factors were potentially involved in the transactiva-
tion of BSEP, and it will be important to identify those
nuclear factors in future studies.
LRH-1 was recruited to LRHRE1
After demonstrating the specific binding of LRH-1 to
LRHRE1 in EMSAs, we next performed ChIP experi-
ments to determine whether LRH-1 is specifically re-
cruited to the element in the BSEP promoter. Chromatins
were prepared from Huh 7 cells transfected with LRH-
1 and immunoprecipitated with anti-LRH-1 antibodies.
A primer set, pBSEP(2260b) and pBSEP(135b), flank-
ing the LRHRE1 site, was used to detect the presence
of LRHRE1-containing chromatin DNA. As shown in
Fig. 6A, an LRHRE1-containing PCR fragment was readily
detected using precipitated chromatins with antibodies
against LRH-1, whereas no PCR products were amplified
in a sample precipitated with IgG antibodies, indicat-
ing the specificity of the assay. To further validate this
finding, a second set of primers, pBSEP(2805b) and
pBSEP(2995b), located 630 bp upstream of the LRHRE1
site, was used as a negative control to amplify a 190 bp
fragment. As shown in Fig. 6A, a PCR product with the
expected size was readily detected with input chromatin
DNA. However, no PCR products were detected with chro-
matin DNA immunoprecipitated with IgG or LRH-1
antibodies, confirming the specificity of the ChIP assay.
We used two additional sets of primers to determine
whether LRH-1 is recruited to LRHRE3 and LRHRE4.
As expected, minimal or no recruitment of LRH-1 to
the LRHRE3 and LRHRE4 sites was detected (Fig. 6A).
Together, these data clearly demonstrate that LRH-1
was specifically recruited to the LRHRE1 element. It
should be mentioned that the recruitment of LRH-1 to
the LRHRE1 site was also detected using nuclear extract
prepared from Huh 7 cells untransfected with LRH-1
expression plasmid, although at a lower level (data not
shown), consistent with the low levels of LRH-1 expression
in Huh 7 cells.
To confirm the finding from Huh 7 cells, we next
performed ChIP assays using chromatins prepared from
human liver tissue. Consistent with the data from Huh
7 cells, an LRHRE1-containing PCR fragment was ro-
bustly detected, which was actually stronger than the sig-
nal detected with input chromatins (Fig. 6B). Again,
minimal signals were detected using the negative control
primer set or chromatins immunoprecipitated with IgG
antibodies. Thus, we demonstrated that LRH-1 was spe-
cifically recruited to the LRHRE1 site in the BSEP
promoter in both Huh 7 cells and human primary hepa-
tocytes. To determine whether such recruitment is af-
fected by the activation of the bile acid/FXR signaling
pathway, ChIP assays were carried out using chromatins
prepared from Huh 7 cells transfected with LRH-1,
followed by treatment with CDCA or vehicle DMSO. As
shown in Fig. 6C, CDCA treatment had no effect on
LRH-1 recruitment to LRHRE1, suggesting that the re-
Fig. 5. LRH-1 specifically bound to LRHRE1 in vitro. Electropho-
retic mobility shift assay (EMSA) was performed using the
LightShift Chemiluminescent EMSA kit (Pierce). Nuclear extracts
were prepared from Huh 7 cells transfected with LRH-1 and
subjected to EMSA analysis with biotin-labeled LRHRE1-specific
probe. The specificity of the binding was established with
competition assays using various competing oligonucleotides,
including unlabeled LRHRE1 (103 and 503) (lanes 3, 4), mutated
LRHRE1 (503Mut) (lane 6), and the LRHRE from human
cholesterol 7a-hydroxylase (CYP7A1; 503) (lane 5). Identification
of LRH-1 in the shifted complex was carried out by a supershift
assay using polyclonal antibodies against human LRH-1 (lane 7). As
a negative control, antibodies against JunB were included in the
experiments (lane 8). The shifted band representing the specific
binding of LRH-1 to the LRHRE1 oligonucleotide is indicated by
the arrow.
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cruitment of LRH-1 to the BSEP promoter is indepen-
dent of bile acid/FXR-mediated activation.
Regulatory role of SHP in BSEP expression
It is well established that SHP negatively regulates a set
of LRH-1 target genes through heterodimerization with
LRH-1 (10–14, 21, 22). The FXR/SHP/LRH-1 pathway
represents a major negative feedback mechanism for bile
acids to regulate those LRH-1 target genes. To explore
the possibility that SHP has a regulatory role in BSEP
expression by interacting with LRH-1, the effect of SHP
on the LRH-1-mediated transactivation of the BSEP pro-
moter was investigated. Huh 7 cells were cotransfected
with the BSEP promoter reporter pBSEP(22.6kb) and
LRH-1 in the absence or presence of increasing amounts
of SHP expression plasmids (0, 10, 25, 100, and 200 ng). As
shown in Fig. 7A, SHP dose-dependently repressed the
LRH-1-mediated transactivation of the BSEP promoter.
These data are consistent with the notion that SHP is a
negative regulator for the LRH-1 target gene by hetero-
dimerizing with LRH-1.
We next performed experiments to determine whether
such repression by SHP is dependent on the presence
of the functional LRHRE1 identified in previous studies.
The effects of SHP on the LRH-1-mediated activation of
pBSEP(22.6kb) (wild type), LRHRE1 Mut, and LRHRE2
Mut were evaluated. As shown in Fig. 7B, SHP repressed
the LRH-1-mediated activation of wild-type pBSEP(22.6kb)
and LRHRE2 Mut by ?50%, but no effect was detected in
cells transfected with LRHRE1 Mut. Although LRHRE1
Mut exhibited a low level of activation (1.5-fold) by LRH-1,
such activation was not repressed further by SHP. These
data suggested that the SHP-mediated repression was de-
pendent on the presence of the functional LRHRE1 in the
BSEP promoter.
The finding that SHP repressed the LRH-1-mediated
transactivation of the BSEP promoter raised the intriguing
question of why BSEP expression is induced by bile acids
through FXR activation but not repressed through the
FXR/SHP/LRH-1 pathway. We hypothesized that activa-
tion mediated by LRH-1 and FXR was dominant over the
SHP-mediated repression in BSEP regulation. To support
this hypothesis, we performed experiments to establish the
expression profile of SHP in responding to LRH-1, FXR,
and bile acid, the same treatments used to establish the
BSEP expression profile in Fig. 3A, followed by compari-
son of the expression profiles of BSEP and SHP. As shown
in Fig. 7C, overexpression of LRH-1 and FXR increased
both basal and CDCA-induced SHP mRNA expression,
a pattern strikingly similar to that observed for BSEP ex-
pression (Fig. 3A). Such paralleling but not inverse expres-
sion patterns between BSEP and SHP appeared not to be
in agreement with the finding that SHP repressed BSEP
promoter transactivation (Fig. 7A, B) but were consistent
Fig. 6. LRH-1 was specifically recruited to LRHRE1 in the BSEP promoter. A: Huh 7 cells seeded on six-well
plates were transfected with LRH-1 expression plasmid (2 mg), and chromatins with optimized size ranging
from 400 to 800 bp were prepared as described in Materials and Methods. After immunoprecipitation with
antibodies against LRH-1 or IgG as a negative control, three sets of PCR amplification were performed to
specifically detect the presence of LRHRE1-, LRHRE3-, or LRHRE4-containing chromatin DNA. A negative
control primer set was included to amplify a 190 bp fragment 630 bp upstream of the LRHRE1 site. PCR
amplification was carried out in a final volume of 25 ml with 2 ml of eluted chromatin DNA, input DNA, or
water (mock) as template with 40 cycles. PCR products were resolved on a 2% agarose gel. B: Chromatins
were prepared from normal human liver tissue and immunoprecipitated with antibodies against LRH-1 or
IgG. The presence of LRHRE1-containing chromatin DNA was detected by PCR amplification using a set of
primers flanking LRHRE1. PCR amplification using the negative control primer set was also performed as a
control. C: Chromatins were prepared from Huh 7 cells transfected with LRH-1 plasmid and subsequently
treated with CDCA (10 mM) or vehicle DMSO (0.1%). The presence of LRHRE1-containing chromatin DNA
was detected by PCR amplification using a set of primers flanking LRHRE1.
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with our hypothesis that activation mediated by LRH-1 and
FXR is dominant over the SHP repression pathway in BSEP
regulation. A similar phenomenon has been reported for
the regulation of SHP (10) and Osta and Ostb (23).
Species differences in the LRH-1-mediated transactivation
of BSEP promoters
We had demonstrated that LRH-1 activated the hu-
man BSEP promoter. To determine whether such activa-
tion is conserved among mouse and rat BSEP, the effects
of LRH-1 on mouse and rat BSEP promoter transactiva-
tion were investigated. Huh 7 cells were cotransfected with
the mouse BSEP promoter reporter pmBSEP(22.6kb) or
the rat BSEP promoter reporter prBSEP(22kb), with
LRH-1 expression plasmid or vector as a control. The pro-
moter activities were detected by the dual luciferase assay.
As shown in Fig. 8A, similar to the finding with the human
BSEP promoter, LRH-1 significantly activated the mouse
BSEP promoter, although at a relatively lower level. How-
ever, such transactivation was not observed with the rat
BSEP promoter. In contrast, slightly decreased transactiva-
Fig. 8. Species differences in the LRH-1-mediated transactiva-
tion of the BSEP promoter. A: Huh 7 cells seeded on 24-well
plates were transfected with 100 ng of the human, mouse, or rat
BSEP promoter reporter [pBSEP(22.6kb), pmBSEP(22.6kb), or
prBSEP(22kb)], 10 ng of the null-Renilla luciferase plasmid, and
100 ng of LRH-1 expression plasmid or vector as a control. Pro-
moter activities were detected with the Dual-Luciferase Reporter
Assay System at 36 h after transfection. The asterisk indicates a
significant difference between vector and LRH-1-treated cells by
Student’s t-test (P , 0.05). Data are presented as means 6 SD of at
least three separate experiments. B: Alignment of the corre-
sponding LRHRE1 sequences in human, mouse, and rat BSEP
promoters. The sequence of the consensus LRHRE is given at
the top of the alignment.
Fig. 7. Regulatory role of small heterodimer partner (SHP) in BSEP
expression. A: Huh 7 cells were transfected with the BSEP promoter
reporter pBSEP(22.6kb) (100 ng), the LRH-1 expression plasmid
(100 ng), and the null-Renilla luciferase plasmid (10 ng) in the ab-
sence or presence of increasing amounts of SHP constructs (0, 5, 25,
100, and 200 ng). Luciferase activities were detected at 36 h after
transfection with the Dual-Luciferase Reporter Assay System. B: Huh
7 cells were cotransfected with 100 ng of the wild-type BSEP pro-
moter reporter pBSEP(22.6kb) (pBSEP-wt), LRHRE1 Mut, LRHRE2
Mut, or pGL4.10 vector, with expression empty vector (100 ng), LRH-1
(100 ng), SHP (50 ng), or a combination of LRH-1 and SHP. Lu-
ciferase activities weredetected at 36hafter transfection.C:Huh7 cells
seeded on 12-well plates were transfected with LRH-1, FXR, or vector
as a control, followed by treatment of transfected cells with CDCA
(10 mM) or vehicle DMSO (0.1%) for 30 h. Total RNA was isolated
and subjected to cDNA synthesis and real-time PCR using the TaqMan
GeneExpressionAssaywith a SHP-specific probe.ThemRNA levels for
GAPDH were detected as internal standards. The PCR cycle time (Ct)
in cells transfected with vector control is given at the top of the col-
umn. The asterisks indicate significant differences (P, 0.05) between
vector control and treatment groups by Student’s t-test. All data are
presented as means 6 SD of at least three separate experiments.
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tion was detected with the rat BSEP promoter, although
the decrease was not statistically significant. These data
suggested that the LRH-1-mediated transactivation of
the BSEP promoter was conserved between human and
mouse but not with rat. It should be mentioned that
BSEP promoters derived from mouse and rat had rela-
tively much higher levels of basal activity than the human
BSEP promoter (23.5- and 23.1-fold increase, respectively;
data not shown). Sequence analysis revealed that the
LRHRE1 site was not completely conserved between
human and mouse or rat. Two and three nucleotides
were substituted in the corresponding mouse and rat se-
quence, respectively, compared with the human LRHRE1
(Fig. 8B). Therefore, it is possible that the LRHRE1-like
site in mouse is still functional in responding to LRH-1,
whereas the three substitutions in the rat sequence result
in total loss of the site. It should be mentioned that a
similar species difference has been reported in the LRH-
1-mediated transactivation of ASBT (20).
DISCUSSION
As the canalicular effluxer of bile acids, the expression
of BSEP is regulated by its substrates bile acids. Bile acids
markedly induce BSEP expression by activating the nu-
clear receptor FXR (15, 16). Such feed-forward regulation
of BSEP expression by bile acids represents a mechanism
for eliminating hepatic bile acids and preventing hepatic
injury as a result of the excessive accumulation of toxic
bile acids. In this study, we showed that BSEP expres-
sion was also transcriptionally regulated by LRH-1, which
functioned as a modulator in the bile acid/FXR-mediated
regulation of BSEP expression, most likely by modu-
lating the basal expression of BSEP. Our finding is con-
sistent with the results obtained with LRH-1 knockout
mice, in which BSEP expression was decreased compared
with that in wild-type mice (30). Thus, BSEP represented
another such target gene that is regulated directly by both
FXR and LRH-1 activation pathways as SHP (10), Osta and
Ostb (23).
It is well established that CYP7A1 is the rate-limiting
enzyme for bile acid synthesis (1, 2). LRH-1 is required
for the maximal hepatic expression of CYP7A1 (19, 20).
With our new finding that LRH-1 also transcriptionally
regulates BSEP expression, it can be concluded that
LRH-1 plays a supporting role to FXR in maintaining
homeostatic bile acid levels in liver by coordinately reg-
ulating CYP7A1 and BSEP for bile acid synthesis and
elimination, respectively. Such coordinated regulation of
CYP7A1 and BSEP through the LRH-1 signaling pathway
favors cholesterol conversion into bile acids and subse-
quent elimination. Therefore, activation of the LRH-1 sig-
naling pathway may represent a new strategy for the
removal of excessive cholesterol from the body, and
LRH-1 agonists potentially have therapeutic effects on hy-
percholesterolemia and related cardiovascular diseases.
In this study, we explored the potential regulatory role
of SHP in BSEP expression and found that SHP dose-
dependently repressed LRH-1-mediated transactivation
of BSEP promoter, consistent with its heterodimerization
with LRH-1 to exert a negative regulatory effect on LRH-1
target genes (10–14, 21, 22). Supporting such a repressive
effect of SHP on BSEP expression is the finding that BSEP
is upregulated in SHP knockout mice (31). However, in
this study, we also demonstrated that BSEP and SHP ex-
hibited similar expression profiles in responding to the
overexpression of LRH-1 and FXR and to CDCA treatment
(Figs. 3A, 7C), which appears inconsistent with SHP’s re-
pressive role in BSEP expression. Therefore, it was sug-
gested that BSEP expression was repressed by SHP but that
activation mediated by LRH-1 and FXR was dominant over
SHP-mediated repression. Such a phenomenon has been
reported for SHP (10), Osta and Ostb (23). One char-
acteristic feature of transcriptional regulation for those
genes as well as BSEP is that they are direct targets for both
LRH-1 and FXR. It appears that those targets are positively
and negatively regulated through the FXR activation path-
way and the FXR/SHP/LRH-1 repression cascade, respec-
tively. Although the physiological significance has not
been clearly defined for such dual regulatory mechanisms,
it can be concluded that the mechanism provides another
layer of regulation to more precisely titrate the expression
of those target genes in responding to different cellular
situations, such as increases of bile acid level.
Species differences in LRH-1-mediated transactivation
have been reported (21). In this study, we showed that,
similar to the finding with the human BSEP promoter,
LRH-1 activated the mouse BSEP promoter, whereas such
transactivation was not observed with the rat BSEP
promoter. Failure of the rat BSEP promoter to respond
to LRH-1 was consistent with the absence of the LRHRE
site in the rat BSEP promoter. Although the LRHRE in
the mouse BSEP promoter was not perfectly conserved,
such a LRHRE-like site may be still functional. However,
additional studies are required to definitively establish the
reason for such species differences. Compared with other
LRH-1 target genes, including CYP7A1 and ABCG5/8, the
human BSEP promoter was much more robustly acti-
vated by LRH-1 (data not shown) (13, 25), indicating gene-
specific differences in LRH-1-mediated activation. Such
gene-specific differences in activation may result from
variations in the sequences of the LRHREs in the respec-
tive promoters. Indeed, LRHRE1 in the BSEP promoter
differs from the LRHREs in human CYP7A1 and ABCG5/
8 by 2 and 3 bases, respectively. Therefore, the LRH-1-
mediated transactivation exhibits clear species- and gene-
specific variations.
We determined that LRHRE1 was responsible for
mediating the transactivation of the BSEP promoter by
LRH-1. Interestingly, disruption of the nearby LRHRE2
site resulted in strongly enhanced transactivation by LRH-
1 and FXR (Fig. 4B, C). One possible explanation for such
an enhancement is that LRH-1 also binds to the LRHRE2
site and that such binding results in competitive inhibi-
tion of the transactivation via the nearby LRHRE1 site.
Supporting this possibility is the finding that LRH-1 also
specifically bound to the LRHRE2 site detected by EMSA
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(data not shown). Another possibility is that the binding of
transcriptional factors other than LRH-1 to the LRHRE2
site interferes in the transactivation signaling pathway
mediated through the LRHRE1 site. We are currently
investigating those possible mechanisms.
In summary, this study demonstrates that LRH-1 tran-
scriptionally regulates BSEP expression through the func-
tional LRHRE1 in the BSEP promoter and functions as
a modulator in the bile acid/FXR-mediated regulation of
BSEP expression. The finding indicates that LRH-1 plays
a supporting role to FXR in maintaining hepatic bile
acid levels by coordinately regulating CYP7A1 and BSEP
for bile acid synthesis and elimination, respectively.
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